Global Wound Biologics Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Wound Biologics Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme based formulations, Biologic Skin Substitutes, xenografts and cell based biogens to promote wound healing. Wound care biologics are being frequently used to treat complex burn injuries in patients with the inadequate skin for grafting. Since then, wound care biologics have been established and used to treat the prevalent problem of most complex chronic wounds such as diabetic foot ulcer and venous leg ulcers.
Wound Biologics report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Wound Biologics market is projected to reach US$ 5003.5 million in 2034, increasing from US$ 3940 million in 2022, with the CAGR of 3.4% during the period of 2024 to 2034. Demand from Hospital and Drugstore are the major drivers for the industry.
Global Wound Care Biologics key players include Smith and Nephew, Organogenesis, MiMedx, Integra, Osiris, etc. Global top five players hold a share about 35%.
North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, having a total share about 35 percent.
In terms of product, Biologic Skin Substitutes is the largest segment, with a share about 55%. And in terms of application, the largest application is Chronic Wounds, followed by Acute Wounds, Surgical Wounds.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Wound Biologics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Avita Medical
ConvaTec
Acelity
Cytori Therapeutic
MacroCure
Nuo Therapeutics
Molyncke Health Care
Osiris Therapeutics
Smith And Nephew
Organogenesis
Segment by Type
Biological Skin Substitutes
Enzyme Preparation
Growth Factor
Hospital
Drugstore
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Wound Biologics market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Wound Biologics, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Wound Biologics industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Wound Biologics in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Wound Biologics introduction, etc. Wound Biologics Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Wound Biologics market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Wound Biologics report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Wound Biologics market is projected to reach US$ 5003.5 million in 2034, increasing from US$ 3940 million in 2022, with the CAGR of 3.4% during the period of 2024 to 2034. Demand from Hospital and Drugstore are the major drivers for the industry.
Global Wound Care Biologics key players include Smith and Nephew, Organogenesis, MiMedx, Integra, Osiris, etc. Global top five players hold a share about 35%.
North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, having a total share about 35 percent.
In terms of product, Biologic Skin Substitutes is the largest segment, with a share about 55%. And in terms of application, the largest application is Chronic Wounds, followed by Acute Wounds, Surgical Wounds.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Wound Biologics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Avita Medical
ConvaTec
Acelity
Cytori Therapeutic
MacroCure
Nuo Therapeutics
Molyncke Health Care
Osiris Therapeutics
Smith And Nephew
Organogenesis
Segment by Type
Biological Skin Substitutes
Enzyme Preparation
Growth Factor
Segment by Application
Hospital
Drugstore
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Wound Biologics market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Wound Biologics, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Wound Biologics industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Wound Biologics in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Wound Biologics introduction, etc. Wound Biologics Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Wound Biologics market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices